01-05-2002 | Conference Report
Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer
Published in: Breast Cancer Research and Treatment | Issue 2/2002
Login to get access